Edwards Lifesciences
1,270 hedge funds and large institutions have $48.2B invested in Edwards Lifesciences in 2022 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 447 increasing their positions, 478 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
15% less funds holding in top 10
Funds holding in top 10: 26 → 22 (-4)
17% less first-time investments, than exits
New positions opened: 114 | Existing positions closed: 137
19% less capital invested
Capital invested by funds: $59.5B → $48.2B (-$11.3B)
Holders
1,270
Holding in Top 10
22
Calls
$182M
Puts
$195M
Top Buyers
| 1 | +$313M | |
| 2 | +$236M | |
| 3 | +$187M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$129M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$95M |
Top Sellers
| 1 | -$224M | |
| 2 | -$158M | |
| 3 | -$133M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$122M |
| 5 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$101M |